Overall market sentiment has been high on Perrigo Company PLC (PRGO) stock lately. PRGO receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With PRGO Stock Today?
Perrigo Company PLC (PRGO) stock is lower by -5.19% while the S&P 500 is higher by 0.63% as of 1:56 PM on Wednesday, Aug 5. PRGO has fallen -$2.86 from the previous closing price of $55.12 on volume of 1,743,367 shares. Over the past year the S&P 500 has risen 16.96% while PRGO is higher by 2.19%. PRGO earned $1.38 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 38.14.
To see InvestorsObserver's Sentiment Score for Perrigo Company PLC click here.
More About Perrigo Company PLC
Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to over the counter and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.
